Extensive evidence suggests that the self-assembly of amyloid-beta peptide (Abeta) is a nucleation-dependent process that involves the formation of several oligomeric intermediates. Despite neuronal toxicity being recently related to Abeta soluble oligomers, results from aggregation studies are often controversial, mainly because of the low reproducibility of several experimental protocols. Here a multimethodological study that included atomic force microscopy (AFM), transmission electron microscopy (TEM), fluorescence microscopy (FLM), mass spectrometry techniques (matrix-assisted laser desorption/ionization time-of-flight [MALDI-TOF] and electrospray ionization quadrupole time-of-flight [ESI-QTOF]), and direct thioflavin T (ThT) fluoresce...
Amyloid deposition has been observed in more than 20 diseases. Each amyloid-related dis...
Despite great efforts, it is not known which oligomeric population of amyloid beta (Aß) peptides is ...
Amyloid beta-protein (Abeta) oligomers may be the proximate neurotoxins in Alzheimer's disease (AD)....
Extensive evidence suggests that the self-assembly of amyloid-beta peptide (Abeta) is a nucleation-d...
Extensive evidence suggests that the self-assembly of amyloid-beta peptide (A beta) is a nucleation-...
Amyloid beta 25-35 [A beta (25-35)], as a peptide model for full-Length A beta in structural and fun...
Cerebral senile plaque is one of the main pathologies of Alzheimer's disease (AD). The amyloid casca...
none4Protein misfolding and aggregation has been related to several human disorders, generally terme...
none7Aggregation and fibril formation of amyloid-beta peptides (A) are central events in the...
Amyloid beta-protein (Abeta) is linked to neuronal injury and death in Alzheimer's disease (AD). Of ...
A general characteristic of aggregation is the multiple interaction and cross-feedback among distinc...
Despite great efforts, it is not known which oligomeric population of amyloid beta (A f) peptides is...
Formation of toxic oligomeric and fibrillar structures by the amyloid beta-protein (Abeta) is linked...
Following our previous in vitro circular dichroism and fluorometric studies on the role of chaperone...
Nonfibrillar assemblies of amyloid β-protein (Aβ) are considered to play primary roles in Alzheimer ...
Amyloid deposition has been observed in more than 20 diseases. Each amyloid-related dis...
Despite great efforts, it is not known which oligomeric population of amyloid beta (Aß) peptides is ...
Amyloid beta-protein (Abeta) oligomers may be the proximate neurotoxins in Alzheimer's disease (AD)....
Extensive evidence suggests that the self-assembly of amyloid-beta peptide (Abeta) is a nucleation-d...
Extensive evidence suggests that the self-assembly of amyloid-beta peptide (A beta) is a nucleation-...
Amyloid beta 25-35 [A beta (25-35)], as a peptide model for full-Length A beta in structural and fun...
Cerebral senile plaque is one of the main pathologies of Alzheimer's disease (AD). The amyloid casca...
none4Protein misfolding and aggregation has been related to several human disorders, generally terme...
none7Aggregation and fibril formation of amyloid-beta peptides (A) are central events in the...
Amyloid beta-protein (Abeta) is linked to neuronal injury and death in Alzheimer's disease (AD). Of ...
A general characteristic of aggregation is the multiple interaction and cross-feedback among distinc...
Despite great efforts, it is not known which oligomeric population of amyloid beta (A f) peptides is...
Formation of toxic oligomeric and fibrillar structures by the amyloid beta-protein (Abeta) is linked...
Following our previous in vitro circular dichroism and fluorometric studies on the role of chaperone...
Nonfibrillar assemblies of amyloid β-protein (Aβ) are considered to play primary roles in Alzheimer ...
Amyloid deposition has been observed in more than 20 diseases. Each amyloid-related dis...
Despite great efforts, it is not known which oligomeric population of amyloid beta (Aß) peptides is ...
Amyloid beta-protein (Abeta) oligomers may be the proximate neurotoxins in Alzheimer's disease (AD)....